All the news

Showing 10 of 52 articles from: Hepatocellular carcinoma (HCC)

Get an RSS feed of these articles

Show

Exploring the risks of liver cancer after successful treatment for hepatitis C virus

CATIE / 13 June 2013
Bayer Initiates Phase III Trial of Regorafenib in Patients with Advanced Liver Cancer

Bayer press release / 16 May 2013
Novel screening tests for liver cancer

Medical Xpress / 26 April 2013
When Standard Liver Cancer Treatment Doesn't Work Or Isn't Possible, New Ablation Technique Holds Promise

Liver Disease News from Medical News Today / 22 April 2013
Liver resection, radiofrequency ablation treated HCC in cirrhotic patients comparably

Healio Hepatology / 12 April 2013
Drinking coffee halves the risk of liver cancer

Michael Carter / 02 April 2013

Coffee consumption reduces the risk of liver cancer by approximately 50%, the results of a meta-analysis published in the online journal BMC Gastroenterology show. A total of 16 studies published before May 2012 ...
Statins tied to lowered liver cancer risk with hepatitis C

Reuters / 22 March 2013
EASL publishes first comprehensive literature review on the burden of liver disease in Europe

Eurekalert Inf Dis / 22 February 2013
Liver cancer has a more aggressive disease course in HIV-positive people co-infected with viral hepatitis

Michael Carter / 18 December 2012

Co-infection with HIV and viral hepatitis is associated with a more aggressive disease course for liver cancer, according to research conducted in London and presented to the recent EASL Monothematic Conference: HIV and ...
Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising

Liz Highleyman / 05 December 2012

The investigational cancer drug brivanib did not significantly increase survival for people with hepatocellular carcinoma over existing standard therapy, researchers reported at the recent Liver Meeting 2012, the 63rd Annual Meeting of ...